Description: This is a brief report that summarizes recent changes in the prevalent medical loss ratio methodologies and also looks at some of the more recent experience of health insurers that filed medical loss ratio reports.

Description: Discusses: Types of medical expense insurance being offered and features, risk management, pricing, and methods of pre-funding retiree benefits.

Description: This is a brief report that summarizes recent changes in the prevalent medical loss ratio methodologies and also looks at some of the more recent experience of health insurers that filed medical loss ratio reports.

Description: This 1977 report provided morbidity experience under individual health policies in force during the 1973 and 1974 calendar years.

Description: Description and layout of the Group Medical Claims Database from the 1997–1999 Group Medical Insurance Database and Analysis Report.

Description: This discussion on major medical expense insurance examines the trends in the types of plans sold, popularity of the comprehensive type of medical expense insurance plan, special problems, and dependent coverage. From Transactions of Society of Actuaries 1959, Vol. 11, No. 29 AB.

Description: Discusses considerations taken in determining desirable limits on the amount of group life insurance per life - apart from legislative restrictions, problems presented in the extension of group medical insurance to retired lives, and recent group medical experience.

Description: WeChat is gradually becoming the main force of insurance online marketing for insurance products in China.

Description: This literature guide provides a basic grounding for product development actuaries.

Description: Through the sponsorship of the Robert Wood Johnson Foundation, The Society of Actuaries partnered with Wakely to use their health care data to study the effects of COVID-19 on overall health care claims for individuals with a COVID-19 diagnosis. The conclusion of the study is that individuals with COVID-19 claims had significant increases in health care costs leading up to their months of diagnosis, as well as in the months following their diagnosis. These effects were more pronounced for individuals who were hospitalized due to COVID-19 as well as for individuals with prior co-morbidities. Finally, the overall health care costs of these members plateaued at significantly higher levels than their pre-COVID baselines. In fact, all the main membership cohorts experienced claim levels that were at least 20% higher than their pre-COVID starting points.